nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—NR3C1—polycystic ovary syndrome	0.859	1	CbGaD
Mometasone—Seasonal allergy—Metformin—polycystic ovary syndrome	0.0156	0.176	CcSEcCtD
Mometasone—Rhinitis seasonal—Metformin—polycystic ovary syndrome	0.0149	0.169	CcSEcCtD
Mometasone—Sinus headache—Metformin—polycystic ovary syndrome	0.01	0.113	CcSEcCtD
Mometasone—Sinus congestion—Metformin—polycystic ovary syndrome	0.00656	0.0743	CcSEcCtD
Mometasone—Contusion—Metformin—polycystic ovary syndrome	0.00374	0.0424	CcSEcCtD
Mometasone—Ear pain—Metformin—polycystic ovary syndrome	0.00278	0.0314	CcSEcCtD
Mometasone—Nasal congestion—Metformin—polycystic ovary syndrome	0.0026	0.0295	CcSEcCtD
Mometasone—Injury—Metformin—polycystic ovary syndrome	0.00258	0.0292	CcSEcCtD
Mometasone—NR3C1—urine—polycystic ovary syndrome	0.00245	0.246	CbGeAlD
Mometasone—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00212	0.024	CcSEcCtD
Mometasone—Influenza—Metformin—polycystic ovary syndrome	0.00205	0.0232	CcSEcCtD
Mometasone—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0019	0.0216	CcSEcCtD
Mometasone—Rhinitis—Metformin—polycystic ovary syndrome	0.00164	0.0186	CcSEcCtD
Mometasone—Immune system disorder—Metformin—polycystic ovary syndrome	0.00148	0.0168	CcSEcCtD
Mometasone—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00148	0.0167	CcSEcCtD
Mometasone—Chest pain—Metformin—polycystic ovary syndrome	0.00121	0.0138	CcSEcCtD
Mometasone—Myalgia—Metformin—polycystic ovary syndrome	0.00121	0.0138	CcSEcCtD
Mometasone—Infection—Metformin—polycystic ovary syndrome	0.00116	0.0131	CcSEcCtD
Mometasone—Anorexia—Metformin—polycystic ovary syndrome	0.00111	0.0126	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00106	0.012	CcSEcCtD
Mometasone—Paraesthesia—Metformin—polycystic ovary syndrome	0.00105	0.0118	CcSEcCtD
Mometasone—Dyspnoea—Metformin—polycystic ovary syndrome	0.00104	0.0118	CcSEcCtD
Mometasone—Dyspepsia—Metformin—polycystic ovary syndrome	0.00102	0.0116	CcSEcCtD
Mometasone—Decreased appetite—Metformin—polycystic ovary syndrome	0.00101	0.0115	CcSEcCtD
Mometasone—Fatigue—Metformin—polycystic ovary syndrome	0.001	0.0114	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—INSR—polycystic ovary syndrome	0.000969	0.0312	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000952	0.0108	CcSEcCtD
Mometasone—Abdominal pain—Metformin—polycystic ovary syndrome	0.00092	0.0104	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—polycystic ovary syndrome	0.000894	0.0288	CbGpPWpGaD
Mometasone—Asthenia—Metformin—polycystic ovary syndrome	0.000835	0.00946	CcSEcCtD
Mometasone—Pruritus—Metformin—polycystic ovary syndrome	0.000823	0.00933	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000808	0.026	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000801	0.0258	CbGpPWpGaD
Mometasone—Diarrhoea—Metformin—polycystic ovary syndrome	0.000796	0.00902	CcSEcCtD
Mometasone—NR3C1—embryo—polycystic ovary syndrome	0.000791	0.0795	CbGeAlD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—polycystic ovary syndrome	0.000763	0.0246	CbGpPWpGaD
Mometasone—Vomiting—Metformin—polycystic ovary syndrome	0.00074	0.00838	CcSEcCtD
Mometasone—Rash—Metformin—polycystic ovary syndrome	0.000734	0.00831	CcSEcCtD
Mometasone—Dermatitis—Metformin—polycystic ovary syndrome	0.000733	0.00831	CcSEcCtD
Mometasone—Headache—Metformin—polycystic ovary syndrome	0.000729	0.00826	CcSEcCtD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000729	0.0235	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—polycystic ovary syndrome	0.00072	0.0232	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000704	0.0227	CbGpPWpGaD
Mometasone—Nausea—Metformin—polycystic ovary syndrome	0.000691	0.00783	CcSEcCtD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—polycystic ovary syndrome	0.000651	0.021	CbGpPWpGaD
Mometasone—NR3C1—adrenal cortex—polycystic ovary syndrome	0.000649	0.0651	CbGeAlD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000648	0.0209	CbGpPWpGaD
Mometasone—CYP2C8—endometrium—polycystic ovary syndrome	0.000647	0.0649	CbGeAlD
Mometasone—NR3C1—Adipogenesis—LIFR—polycystic ovary syndrome	0.00061	0.0197	CbGpPWpGaD
Mometasone—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000585	0.0588	CbGeAlD
Mometasone—NR3C1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000579	0.0187	CbGpPWpGaD
Mometasone—NR3C1—endometrium—polycystic ovary syndrome	0.000579	0.0581	CbGeAlD
Mometasone—NR3C1—uterus—polycystic ovary syndrome	0.000534	0.0536	CbGeAlD
Mometasone—NR3C1—pituitary gland—polycystic ovary syndrome	0.000524	0.0526	CbGeAlD
Mometasone—NR3C1—adipose tissue—polycystic ovary syndrome	0.000522	0.0524	CbGeAlD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000515	0.0166	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—polycystic ovary syndrome	0.000513	0.0165	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—polycystic ovary syndrome	0.000502	0.0162	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—LIF—polycystic ovary syndrome	0.000497	0.016	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—RETN—polycystic ovary syndrome	0.000497	0.016	CbGpPWpGaD
Mometasone—Testolactone—CYP19A1—polycystic ovary syndrome	0.000491	0.0422	CrCbGaD
Mometasone—CYP2C8—vagina—polycystic ovary syndrome	0.000484	0.0486	CbGeAlD
Mometasone—NR3C1—Circadian Clock—NAMPT—polycystic ovary syndrome	0.000474	0.0153	CbGpPWpGaD
Mometasone—NR3C1—adrenal gland—polycystic ovary syndrome	0.000468	0.047	CbGeAlD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000458	0.0148	CbGpPWpGaD
Mometasone—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000453	0.0455	CbGeAlD
Mometasone—NR3C1—Nuclear Receptors—AR—polycystic ovary syndrome	0.00045	0.0145	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—polycystic ovary syndrome	0.000447	0.0144	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—polycystic ovary syndrome	0.000437	0.0141	CbGpPWpGaD
Mometasone—NR3C1—female gonad—polycystic ovary syndrome	0.000437	0.0438	CbGeAlD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000435	0.014	CbGpPWpGaD
Mometasone—NR3C1—vagina—polycystic ovary syndrome	0.000434	0.0436	CbGeAlD
Mometasone—Difluprednate—NR3C1—polycystic ovary syndrome	0.000411	0.0353	CrCbGaD
Mometasone—NR3C1—endocrine gland—polycystic ovary syndrome	0.000406	0.0408	CbGeAlD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—polycystic ovary syndrome	0.000402	0.013	CbGpPWpGaD
Mometasone—Prednicarbate—NR3C1—polycystic ovary syndrome	0.000398	0.0342	CrCbGaD
Mometasone—Clocortolone—NR3C1—polycystic ovary syndrome	0.000398	0.0342	CrCbGaD
Mometasone—CYP2C8—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000385	0.0124	CbGpPWpGaD
Mometasone—Desonide—NR3C1—polycystic ovary syndrome	0.000377	0.0324	CrCbGaD
Mometasone—Diflorasone—NR3C1—polycystic ovary syndrome	0.000377	0.0324	CrCbGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00037	0.0119	CbGpPWpGaD
Mometasone—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000367	0.0316	CrCbGaD
Mometasone—Loteprednol—NR3C1—polycystic ovary syndrome	0.000363	0.0312	CrCbGaD
Mometasone—Fludrocortisone—AR—polycystic ovary syndrome	0.000358	0.0308	CrCbGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000356	0.0115	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000346	0.0111	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000346	0.0111	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—AR—polycystic ovary syndrome	0.000345	0.0111	CbGpPWpGaD
Mometasone—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.000337	0.029	CrCbGaD
Mometasone—Flumethasone Pivalate—NR3C1—polycystic ovary syndrome	0.000316	0.0272	CrCbGaD
Mometasone—Halobetasol Propionate—NR3C1—polycystic ovary syndrome	0.000311	0.0267	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.000311	0.01	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000307	0.0099	CbGpPWpGaD
Mometasone—Fluticasone Propionate—PGR—polycystic ovary syndrome	0.000307	0.0264	CrCbGaD
Mometasone—Fluoxymesterone—AR—polycystic ovary syndrome	0.000296	0.0254	CrCbGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000294	0.00948	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—NCOR1—polycystic ovary syndrome	0.000293	0.00944	CbGpPWpGaD
Mometasone—Budesonide—NR3C1—polycystic ovary syndrome	0.000289	0.0249	CrCbGaD
Mometasone—Amcinonide—NR3C1—polycystic ovary syndrome	0.000289	0.0249	CrCbGaD
Mometasone—Fluticasone furoate—NR3C1—polycystic ovary syndrome	0.000284	0.0244	CrCbGaD
Mometasone—NR3C1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000282	0.00909	CbGpPWpGaD
Mometasone—Betamethasone—PGR—polycystic ovary syndrome	0.000281	0.0241	CrCbGaD
Mometasone—Rimexolone—NR3C1—polycystic ovary syndrome	0.000272	0.0234	CrCbGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000269	0.00868	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000266	0.00857	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—polycystic ovary syndrome	0.00026	0.00837	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000258	0.0083	CbGpPWpGaD
Mometasone—Fluocinonide—NR3C1—polycystic ovary syndrome	0.000257	0.022	CrCbGaD
Mometasone—Beclomethasone—NR3C1—polycystic ovary syndrome	0.000257	0.022	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—PRL—polycystic ovary syndrome	0.000254	0.00818	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000252	0.00813	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00025	0.00807	CbGpPWpGaD
Mometasone—Alclometasone—NR3C1—polycystic ovary syndrome	0.000249	0.0214	CrCbGaD
Mometasone—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000249	0.0214	CrCbGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000247	0.00796	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000246	0.00793	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.000246	0.00792	CbGpPWpGaD
Mometasone—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000243	0.0209	CrCbGaD
Mometasone—Fludrocortisone—NR3C1—polycystic ovary syndrome	0.000243	0.0209	CrCbGaD
Mometasone—Flunisolide—NR3C1—polycystic ovary syndrome	0.000243	0.0209	CrCbGaD
Mometasone—Paramethasone—NR3C1—polycystic ovary syndrome	0.00024	0.0206	CrCbGaD
Mometasone—NR3C1—Adipogenesis—NAMPT—polycystic ovary syndrome	0.000238	0.00768	CbGpPWpGaD
Mometasone—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000234	0.0201	CrCbGaD
Mometasone—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000226	0.0194	CrCbGaD
Mometasone—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.000226	0.00728	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000223	0.00719	CbGpPWpGaD
Mometasone—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.00022	0.0189	CrCbGaD
Mometasone—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.00022	0.0189	CrCbGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000218	0.00704	CbGpPWpGaD
Mometasone—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000217	0.0186	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000215	0.00693	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000207	0.00668	CbGpPWpGaD
Mometasone—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000205	0.0176	CrCbGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000203	0.00654	CbGpPWpGaD
Mometasone—Fluoxymesterone—NR3C1—polycystic ovary syndrome	0.0002	0.0172	CrCbGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000198	0.00639	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000196	0.0063	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000195	0.00628	CbGpPWpGaD
Mometasone—Betamethasone—CYP19A1—polycystic ovary syndrome	0.000193	0.0166	CrCbGaD
Mometasone—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000191	0.0164	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000189	0.00611	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000189	0.00609	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.000187	0.00603	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000185	0.00596	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.000184	0.00593	CbGpPWpGaD
Mometasone—Prednisone—NR3C1—polycystic ovary syndrome	0.000173	0.0149	CrCbGaD
Mometasone—Fluticasone Propionate—NR3C1—polycystic ovary syndrome	0.00017	0.0146	CrCbGaD
Mometasone—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000166	0.00537	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000166	0.00537	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000164	0.00527	CbGpPWpGaD
Mometasone—Dexamethasone—PGR—polycystic ovary syndrome	0.000163	0.014	CrCbGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000161	0.00518	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00016	0.00515	CbGpPWpGaD
Mometasone—Prednisolone—NR3C1—polycystic ovary syndrome	0.000159	0.0137	CrCbGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000158	0.00508	CbGpPWpGaD
Mometasone—Betamethasone—NR3C1—polycystic ovary syndrome	0.000156	0.0134	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	0.00015	0.00485	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	0.000147	0.00474	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000146	0.00469	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000142	0.00456	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00014	0.00452	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000139	0.00447	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000131	0.00422	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000129	0.00417	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000129	0.00416	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000124	0.004	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	0.000124	0.00399	CbGpPWpGaD
Mometasone—Hydrocortisone—NR3C1—polycystic ovary syndrome	0.000122	0.0105	CrCbGaD
Mometasone—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	0.000121	0.0039	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000119	0.00384	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000116	0.00374	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	0.000115	0.00372	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000114	0.00369	CbGpPWpGaD
Mometasone—Dexamethasone—CYP19A1—polycystic ovary syndrome	0.000112	0.00964	CrCbGaD
Mometasone—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	0.000108	0.00348	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000108	0.00348	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000108	0.00347	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000107	0.00346	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000106	0.00343	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	0.000105	0.0034	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	0.000103	0.00333	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	0.0001	0.00322	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	9.82e-05	0.00317	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	9.82e-05	0.00317	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	9.65e-05	0.00311	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	9.5e-05	0.00306	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	9.12e-05	0.00294	CbGpPWpGaD
Mometasone—Dexamethasone—NR3C1—polycystic ovary syndrome	9.09e-05	0.00781	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	9.05e-05	0.00292	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP19A1—polycystic ovary syndrome	8.53e-05	0.00275	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	8.42e-05	0.00271	CbGpPWpGaD
Mometasone—Dexamethasone—CYP1A1—polycystic ovary syndrome	8.25e-05	0.00709	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	8.23e-05	0.00265	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	7.91e-05	0.00255	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	7.8e-05	0.00251	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	7.44e-05	0.0024	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	7.42e-05	0.00239	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.88e-05	0.00222	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.78e-05	0.00219	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	6.54e-05	0.00211	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	6.5e-05	0.00209	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	6.33e-05	0.00204	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	6.15e-05	0.00198	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	6.05e-05	0.00195	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.77e-05	0.00186	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.65e-05	0.00182	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.64e-05	0.00182	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	5.53e-05	0.00178	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	5.53e-05	0.00178	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	5.46e-05	0.00176	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	5.37e-05	0.00173	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	5.14e-05	0.00166	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	5.13e-05	0.00165	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	5.03e-05	0.00162	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.69e-05	0.00151	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	4.52e-05	0.00146	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.45e-05	0.00144	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	4.37e-05	0.00141	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	4.37e-05	0.00141	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	4.36e-05	0.0014	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	4.21e-05	0.00136	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	4.14e-05	0.00133	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.91e-05	0.00126	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.85e-05	0.00124	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	3.85e-05	0.00124	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	3.81e-05	0.00123	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	3.67e-05	0.00118	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	3.47e-05	0.00112	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.47e-05	0.00112	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	3.31e-05	0.00107	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.28e-05	0.00106	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AR—polycystic ovary syndrome	2.96e-05	0.000954	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	2.95e-05	0.000952	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	2.82e-05	0.000908	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.79e-05	0.000898	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.64e-05	0.000851	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	2.59e-05	0.000834	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	2.57e-05	0.000828	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	2.51e-05	0.00081	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	2.43e-05	0.000784	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	2.24e-05	0.000722	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	2.17e-05	0.000699	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	2.09e-05	0.000674	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	2.01e-05	0.000647	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2e-05	0.000643	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.98e-05	0.000639	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.97e-05	0.000635	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.87e-05	0.000604	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.85e-05	0.000598	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.84e-05	0.000594	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.67e-05	0.000538	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.6e-05	0.000514	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.55e-05	0.0005	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.46e-05	0.00047	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.3e-05	0.00042	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	1.24e-05	0.0004	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	1.18e-05	0.000379	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	1.1e-05	0.000353	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	8.89e-06	0.000287	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	8.77e-06	0.000283	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—INS—polycystic ovary syndrome	8.72e-06	0.000281	CbGpPWpGaD
